Susquehanna International Group
NXTC icon

Susquehanna International Group’s NextCure NXTC Stock Holding History

Susquehanna International Group’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,683
Closed -$155K – 13298
2022
Q3 		$155K Buy
4,683
+475
+11% +$24.2K ﹤0.01% 11190
2022
Q2 		$237K Sell
4,208
-209
-5% -$10.9K ﹤0.01% 10195
2022
Q1 		$258K Buy
4,417
+875
+25% +$54.8K ﹤0.01% 10635
2021
Q4 		$255K Sell
3,542
-41
-1% -$3.43K ﹤0.01% 10877
2021
Q3 		$290K Sell
3,583
-6,500
-64% -$570K ﹤0.01% 10677
2021
Q2 		$972K Sell
10,083
-3,517
-26% -$360K ﹤0.01% 7858
2021
Q1 		$1.63M Buy
13,600
+8,042
+145% +$1.16M ﹤0.01% 6418
2020
Q4 		$727K Sell
5,558
-367
-6% -$47.4K ﹤0.01% 7447
2020
Q3 		$626K Buy
5,925
+2,308
+64% +$284K ﹤0.01% 7204
2020
Q2 		$930K Buy
3,617
+2,650
+274% +$1.01M ﹤0.01% 6087
2020
Q1 		$430K Sell
967
-108
-10% -$57.7K ﹤0.01% 7244
2019
Q4 		$727K Buy
+1,075
New +$539K ﹤0.01% 6184

Other funds holding NXTC

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CPA
Cardiff Park Advisors Carlsbad, California $1.25B AUM 24.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group's NXTC Position: Q3 2025 in Review

Susquehanna International Group sold out of NextCure (NXTC) in Q3 2025, closing a stake of 2,459 shares — an estimated $13.6K sold.

Susquehanna International Group first reported a position in NXTC in Q4 2019 and held it in 12 quarters. The position peaked at $542K in Q4 2021. 17 funds tracked by Wall St. Rank hold NXTC as of Q3 2025.

  • Susquehanna International Group reported no remaining NextCure position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 2,459 NextCure shares in Q3 2025, an estimated $13.6K.
  • Susquehanna International Group first reported a position in NextCure in Q4 2019 and held it in 12 quarters.
  • Susquehanna International Group's NextCure position peaked at $542K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held NextCure as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.